In a retrospective study, the success rates of laserdacryoplasty using a diode laser were defined and compared to success rates using an erbium : YAG laser. Using a diode laser at a wave length of 980 nm, thermal destruction of tissue leads to recanalization. Using an erbium : YAG laser at a wave length of 2940 nm, recanalization of punctual stenosis is achieved by formation of a cavitation bubble in a closed system. 94 patients (64 women, 30 men, mean age 60.8 years) with 107 absolute lacrimal duct stenoses who were treated by laserdacryoplasty using a diode laser were included in a retrospective study. First dacryoendoscopy was performed in general anesthesia showing 40 canalicular and 67 saccal stenoses. As for being punctual, complete stenoses indication for laserdacryoplasty was given. Recanalization was followed by bicanalicular intubation with silicon tubes being left for 95 ± 37 days on average. Lacrimal irrigation was performed in 75 cases of 65 patients 3 months after operation. Approximately 12 months postoperatively, 61 patients were questioned about epiphora and their satisfaction. After 3 months, irrigation was successful in 70.7%, less or no epiphora could be observed in 62.9%, 60% of the patients were satisfied with the result and complication rate was low. In case of saccal stenosis, irrigation was successful in 78.7%, and in cases of canalicular stenosis, irrigation was successful in 57.2%. Clear reflux preoperatively showing no indication of inflammation was prognostically favorable as well as a short duration of symptoms. Laserdacryoplasty using a diode laser shows similar results as using an erbium : YAG laser. This minimally invasive technique rarely leads to complications and is suitable for therapy of punctual canalicular and saccal stenoses.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.